Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tryptamine Therapeutics ( (AU:TYP) ) has shared an update.
Tryptamine Therapeutics Limited has released its corporate governance statement for the financial year ending June 30, 2025, which has been approved by the board and is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations, detailing the roles and responsibilities of the board and management, and the processes followed for director appointments and accountability, reflecting the company’s commitment to transparency and regulatory compliance.
More about Tryptamine Therapeutics
Average Trading Volume: 1,585,657
Technical Sentiment Signal: Sell
Current Market Cap: A$47.5M
Find detailed analytics on TYP stock on TipRanks’ Stock Analysis page.